1)- Mehri Mirrahimi, Zahra Alamzadeh, Jaber Beik, Abolfazl Sarikhani, Mahdie Mousavi, Rasoul Irajirad, Tahereh Khani, Elnaz S Davani, Ali Farashahi, Tahereh Shakerian Ardakani, Jeff W M Bulte, Habib Ghaznavi, Ali Shakeri-Zadeh. A 2D nanotheranostic platform based on graphene oxide and phase-change materials for bimodal CT/MR imaging, NIR-activated drug release, and synergistic thermo-chemotherapy.Nanotheranostics. 2022, 6 (4): 350-364
4)- Emanuel Sporer, Christian B M Poulie, Tom Bäck, Sture Lindegren, Holger Jensen, Paul J Kempen, Andreas Kjaer, Matthias M Herth, Andreas I Jensen. Covalent core-radiolabeling of polymeric micelles with I/At for theranostic radiotherapy.Nanotheranostics. 2022, 6 (4): 388-399
5)- Sareh Mosleh-Shirazi, Milad Abbasi, Mohammad Reza Moaddeli, Ahmad Vaez, Mostafa Shafiee, Seyed Reza Kasaee, Ali Mohammad Amani, Saeid Hatam. Nanotechnology Advances in the Detection and Treatment of Cancer: An Overview.Nanotheranostics. 2022, 6 (4): 400-423
6)- Nagavendra Kommineni, David Paul, Raju Saka, Wahid Khan, Satheeshkumar Nanjappan. Stealth Liposomal Chemotherapeutic Agent for Triple Negative Breast Cancer with Improved Pharmacokinetics.Nanotheranostics. 2022, 6 (4): 424-435
8)- Md Rakibul Islam, Jalpa Patel, Patricia Ines Back, Hilary Shmeeda, Konstantin Adamsky, Hui Yang, Carlos Alvarez, Alberto A Gabizon, Ninh M La-Beck. Comparative effects of free doxorubicin, liposome encapsulated doxorubicin and liposome co-encapsulated alendronate and doxorubicin (PLAD) on the tumor immunologic milieu in a mouse fibrosarcoma model.Nanotheranostics. 2022, 6 (4): 451-464